The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developi...
The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developing therapeutics leading to clinical trials and commercialization. Aspects of our work includedeveloping novel approaches to immuno-oncology, andSuccess in this venture will address pressing unmet medical needs and establish Hong Kong as a leading hub of innovative anti-cancer and immuno-oncology drug development.
Applicants should have a good command of written and spoken English, strong communication skills, and be self-motivated, hardworking and able to work well in an interdisciplinary team.Overseas graduates are welcome to apply; the qualification awarding institution should be ranked in the top 100 institutions for STEM-related subjects in QS/Shanghai Jiao Tong Uni/Times Higher Education/U.S. News world university rankings.
A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.Applicants should submit a C.V. and research publication list, quoting the job reference number, with information of current/expected remuneration and availability, to [email protected] personal data provided in your application process will be used for recruitment and other employment-related purposes.
Under the auspices of the InnoHK initiative, the Centre for Oncology and Immunology aims to harness the power of biotechnology to develop innovative therapies to combat these hard-to-treat malignancies and bring hope to millions of cancer patients around the world. The Centre for Oncology and Immunology is co-led by Professor Tak MAK and Professor Suet-Yi LEUNG of the Department of Pathology at HKUMed in discovering novel therapies in cancer treatment.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Molecular Biologist/Immunologist on the Bethesda NIH campus - Bethesda, Maryland (US) job with National Institutes of HealthDr. Warren J. Leonard’s laboratory in the Immunology Center, National Heart, Lung, and Blood Institute
Read more »
Assistant or Associate Professor, Cancer Immunology and Immunotherapy - Houston, Texas (US) job with Baylor College of Medicine (BCM)Assistant or Associate Professor, Cancer Immunology and Immunotherapy
Read more »
Coinbase takes equity stake in Circle as USDC Centre Consortium shuts downUSDC stablecoin issuer Circle and cryptocurrency exchange Coinbase have altered the terms of USDC governance since their Centre Consortium has become obsolete, they said.
Read more »
Coinbase to invest in Circle, shut down jointly managed Centre By ReutersCoinbase to invest in Circle, shut down jointly managed Centre
Read more »
Murray & Roberts Cementation takes centre stage at CE Safety awardsMurray & Roberts Cementation emerged as a shining beacon of commitment to safety at the annual Murray & Roberts Group’s CE Safety Recognition awards in June. These awards, which spotlight various operations across group companies, recognised Murray & Roberts Cementation for its exceptional safety performance. As a leading underground mining contractor, the company has several projects under its belt that affirm its dedication to safety and the ultimate goal of achieving Zero Harm. One of its standout projects is the Venetia Underground Project (VUP). Collaborating with De Beers Group, Murray & Roberts Cementation played a pivotal role in developing and equipping this underground mine which has seen the transition of Venetia Mine from an open pit operation to an underground mine. Hard work and emphasis on safety by the VUP team earned the project the accolade of 'Best Employee Participation Programme (Leading Indicator Reporting)'.
Read more »
Murray & Roberts Cementation takes centre stage at CE Safety awardsMurray & Roberts Cementation emerged as a shining beacon of commitment to safety at the annual Murray & Roberts Group’s CE Safety Recognition awards in June. These awards, which spotlight various operations across group companies, recognised Murray & Roberts Cementation for its exceptional safety performance. As a leading underground mining contractor, the company has several projects under its belt that affirm its dedication to safety and the ultimate goal of achieving Zero Harm. One of its standout projects is the Venetia Underground Project (VUP). Collaborating with De Beers Group, Murray & Roberts Cementation played a pivotal role in developing and equipping this underground mine which has seen the transition of Venetia Mine from an open pit operation to an underground mine. Hard work and emphasis on safety by the VUP team earned the project the accolade of 'Best Employee Participation Programme (Leading Indicator Reporting)'.
Read more »